Georgia Life Sciences: Anti-Racism Statement and Commitment to Diversity, Equity, and Inclusion

The Georgia Life Sciences staff believe that diversity, equity, and inclusion are fundamental to the progress and success of the life sciences industry. Our mission—improving access to innovative technologies and advancing the health and well-being of people worldwide—can only be fully realized when every voice is heard, valued, and respected.


We unequivocally denounce all forms of racism, discrimination, and hate. Our organization stands firmly against any actions or words that seek to divide us based on race, ethnicity, religion, gender, or any other identity. These values are non-negotiable and are central to who we are as an organization.

 

As we continue to advocate for the growth of Georgia’s life sciences economy, we are also committed to fostering an environment where diversity thrives, equity is pursued, and inclusion is practiced every day. We recognize that a diverse community of professionals brings a wealth of perspectives and ideas that drive innovation and excellence, which are critically important in healthcare.


To reinforce our commitment to these principles, Georgia Life Sciences is taking proactive steps to ensure that our organization not only talks about diversity, equity, and inclusion but lives by these values. These steps include:


  • Diverse Representation: We are committed to ensuring diverse representation across all levels of our organization, including our board, leadership, and membership.
  • Equitable Practices: We will continuously review and improve our policies to ensure they promote equity and fairness for all, particularly in our hiring practices, partnerships, and member services.
  • Inclusive Culture: We are dedicated to creating a culture where everyone feels welcome and respected. We will provide ongoing training and resources to our staff and members to build awareness and skills in areas of diversity, equity, and inclusion.
  • Community Engagement: We will actively engage with underrepresented communities to ensure their voices are included in shaping the future of the life sciences industry.

 

Georgia Life Sciences remains steadfast in its commitment to creating a more just and inclusive society. We understand that this is an ongoing journey, and we are fully dedicated to learning, growing, and taking the necessary actions to uphold our values.


We invite our members, partners, and stakeholders to join us in this important work. Together, we can build a life sciences community that truly reflects the diversity of the world we serve.

By Maria Thacker Goethe April 18, 2025
The Science & Community Impacts Mapping Project (SCIMaP) shows how proposed federal funding cuts lead to reduced economic activity and job losses nationwide.
By Sheran Brown April 10, 2025
Georgia Life Sciences Selects Fulton County Schools Innovation Academy Student as the 2025 Georgia BioGENEius Winner Sandy Springs & Rockmart Teens Take Top Honors in Statewide Science Competition Atlanta, GA (April 4, 2025) – Georgia Life Sciences today named Bhavya Alapati , a junior at Fulton County Schools Innovation Academy, as the winner of the 2025 Georgia BioGENEius Challenge, the premier competition for high school students that recognizes outstanding research and innovation in the biotechnology field. Eleven students from across Georgia competed for this year’s title and cash prize. Bhavya’s project investigated a novel method of identifying strokes using a device she created called SpectroStroke, a small-scale spectrophotometer, to detect homocysteine, an amino acid product that is associated with stroke. Bhavya identified the ability of homocysteine to be detected using Ellman’s reagent, which reacts with the free sulfhydryl group on the molecule to produce a yellow color. Bhavya created a wearable patch that contains the Ellman’s reagent. Then, she designed the SpectroStroke to be able to detect the color change when the patch is exposed to elevated levels of homocysteine. Bhavya’s SpectroStroke can detect normal levels of homocysteine up to extremely high levels seen in those experiencing a stroke. The ability to detect a stroke earlier would reduce damage and long-term effects of the condition. A future iteration of the SpectroStroke would include real-time monitoring capabilities to help track changing homocysteine levels. "Supporting and celebrating outstanding research and innovation in biotechnology is vital for the future of science and medicine. The Georgia BioGENEius Challenge not only encourages the brightest young minds to explore their potential but also nurtures the next generation of leaders who will drive groundbreaking advancements in biotechnology,” said Georgia Life Sciences President and CEO Maria Thacker-Goethe. “By recognizing and empowering these students, we are helping to shape a future where innovation thrives and the possibilities for improving lives are endless. Well done, Bhavya!” Georgia Life Sciences also congratulates the Georgia BioGENEius runner-up, Shelby Kendrick , who is a senior at Paulding County High School in Dallas, GA. Shelby’s research investigated the ability of Aspergillus terreus, a fungus found in soil, to degrade pre-treated polypropylene plastic (PP). This fungus has been discovered to produce high concentrations of degrading enzymes and raises the moisture level of its substrate. Shelby isolated the fungus from soil samples and confirmed the species using PCR amplification and DNA barcoding. Samples of polypropylene were pre-treated with 75% ethanol and UV exposure, then placed in a liquid culture of A. terreus in Minimal Salt Medium (MSM) media, and the culture was incubated for 23 days. At the end of the trial period, PP samples were analyzed using Scanning Electron Microscopy. These samples showed changes in their surface layer, indicating evidence of biodegradation. Polypropylene plastic is found in household items such as plastic cups and is a known problem in the environment due to its inability to degrade. Shelby’s future research on the use of A. terreus for biodegradation includes optimizing degradation conditions and assessing methods of application in the environment. Judging the 2025 Georgia BioGENEius Challenge were Ralph L. Cordell, CDC, and Alex Harvey, ViaMune. Cash prizes were awarded to Bhavya and Shelby. # # # About Georgia Life Sciences Georgia Life Sciences, founded in 1989, is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry. It is the state’s largest and most influential life sciences advocacy and business leadership organization working to improve access to innovative discoveries that have lifesaving impact. The association connects business, academia, government, and other allied entities involved in the application of life sciences products to fuel growth and collaboration through policy development, community programs, national industry initiatives, and a portfolio of educational and networking events. Learn more at galifesciences.org.
By Maria Thacker Goethe April 9, 2025
Emerging biotechnology is key for U.S. to remain dominant and secure future economic growth in a new era of global competition
MORE POSTS